Table 4.
Sensitivity (95% CI) | Specificity (95% CI) | Optimal threshold value | AUC (95% CI) | P-value | |
---|---|---|---|---|---|
BODE index | 78.1 (60.0–90.7) | 73.6 (64.1–81.7) | >4 | 0.776 (0.692–0.845) | <0.0001 |
DOSE index | 21.9 (9.3–40.0) | 87.1 (78.5–93.2) | >4 | 0.504 (0.413–0.594) | 0.952 |
SCOPEX index | 84.4 (67.2–94.7) | 51.6 (41.0–62.1) | >39 | 0.738 (0.652–0.813) | <0.0001 |
NEXA | 56.3 (37.7–40.0) | 66.7 (56.1–76.1) | >1 | 0.632 (0.541–0.717) | 0.02 |
Abbreviations: AECOPD, acute exacerbation of COPD; AUC, area under the receiver operating characteristics curve; BODE, body mass index, airway obstruction, dyspnea, exercise capacity; DOSE, dyspnea, obstruction, smoking, exacerbation; NEXA, number of AECOPD episodes in the year preceding enrolment; SCOPEX, score to predict short-term risk of COPD exacerbations.